Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Country / region: France Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20052
20082
20091
20111
20133
20142
20162
20173
20191
20216
20224
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting8
Active, not recruiting5
Terminated5
Not yet recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Eli Lilly and Company3
Gilead Sciences3
Assistance Publique - Hôpitaux de Paris2
BeOne Medicines2
Centre Hospitalier Universitaire, Amiens2
French Innovative Leukemia Organisation2
AbbVie1
Acerta Pharma BV1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia40
Lymphoma, B-Cell, Marginal Zone22
Leukemia, Lymphocytic, Chronic, B-Cell20
Lymphoma, Follicular20
Lymphoma, Mantle-Cell19
Lymphoma, Non-Hodgkin17
Lymphoma, Large B-Cell, Diffuse14
Burkitt Lymphoma9
Lymphoma9
Multiple Myeloma9

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.